Apollo Endosurgery
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Apollo Endosurgery generated cash of -$31,262,000, which is less than the previous year. Cash used in financing activities reached the amount of $349,000 last year. Net change in cash is therefore -$33,800,000.
Cash Flow
| 2013 | -13.14M | -391.05K | 770.75K |
|---|---|---|---|
| 2014 | -15.18M | -535.91K | 21.15M |
| 2015 | -11.86M | -291.15K | 3.76M |
| 2016 | -12.90M | -2.16M | 12.61M |
| 2017 | -13.32M | -2.13M | 26.70M |
| 2018 | -23.11M | 7.11M | 9.69M |
| 2019 | -25.62M | 1.03M | 30.50M |
| 2020 | -20.81M | 1.37M | 25.61M |
| 2021 | -14.45M | 1.56M | 67.58M |
| 2022 | -31.26M | -2.74M | 349K |
APEN Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 91.81M | 37.2M | 30.92M | 25.00M | 31.41M | 20.04M | 22.58M | 17.28M | 11.85M | 24.62M |
Operating activities | ||||||||||
Net income | -39.83M | -24.68M | -22.61M | -27.43M | -45.78M | -27.29M | -41.16M | -10.01M | -16.55M | -6.56M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.96M | 3.23M | 3.73M | 4.06M | 9.29M | 9.71M | 9.09M | 466.98K | 216.08K | 196.22K |
Stock-based compensation expense | 6.78M | 6.38M | 2.11M | 1.48M | 0 | 0 | 0 | 0 | 0 | 837.27K |
| Deferred income tax benefit | 6.78M | 6.38M | 2.11M | 1.48M | 0 | 0 | 0 | 0 | 0 | 837.27K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -5.58M | -2.33M | 1.07M | 1.85M | -162K | -916K | -426K | 720.19K | 582.85K | -1.07M |
Inventories | -6.43M | -1.74M | -1.55M | 872K | 3.00M | -2.85M | -3.05M | 0 | 0 | 0 |
Accounts payable | 5.77M | 0 | 0 | 0 | -1.26M | 4.73M | 523K | 0 | 0 | 0 |
Cash generated by operating activities | -31.26M | -14.45M | -20.81M | -25.62M | -23.11M | -13.32M | -12.90M | -11.86M | -15.18M | -13.14M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2.74M | -1.45M | -630K | -980K | -2.88M | -2.13M | -2.36M | -291.15K | -535.91K | -391.05K |
Acquisitions Net | 0 | 3M | 2M | 2M | 10M | 0 | 200K | 0 | 0 | 0 |
Cash generated by investing activities | -2.74M | 1.56M | 1.37M | 1.03M | 7.11M | -2.13M | -2.16M | -291.15K | -535.91K | -391.05K |
Financing activities | ||||||||||
Common Stock Issued | 1.22M | 69.78M | 23.26M | 0 | 21.85M | 33.58M | 29M | 3.72M | 21.23M | 802.59K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 153.97M | 0 | 0 | 0 |
Repayments of term debt | 0 | -38.15M | 0 | 0 | -12.5M | 0 | -11.22M | 0 | 0 | 0 |
Cash used in financing activities | 349K | 67.58M | 25.61M | 30.50M | 9.69M | 26.70M | 12.61M | 3.76M | 21.15M | 770.75K |
Net Change In Cash | -33.8M | 54.61M | 6.27M | 5.91M | -6.41M | 11.37M | -2.54M | -8.39M | 5.43M | -12.76M |
Cash at end of period | 58.01M | 91.81M | 37.2M | 30.92M | 25.00M | 31.41M | 20.04M | 8.88M | 17.28M | 11.85M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |